SAN FRANCISCO, CA, June 29, 2026 (EZ Newswire) — Edison Scientific and Population Health Partners (PHP) today announced a strategic partnership to create and launch new biotechnology companies focused ...

The drug and biotech sector is in a recovery mode, after going through a difficult period between 2022 and 2024, backed by ...

By Deena Beasley SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials than the U.S., still lags ...

By Deena Beasley SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials than the U.S., still lags in several key areas of biotechnology innovation, according to a recent ...

While biopharma’s overarching mission is to develop innovative medicines to improve patient outcomes, for these six people, ...

VeriSIM Life was founded to solve that problem. The company's core platform, BIOiSIM, is a hybrid mechanistic-AI system that integrates mechanistic quantitative models and machine learning into a ...

VERAXA Biotech (NASDAQ: VRXA), an emerging developer of novel cancer therapies, announced it has expanded its laboratory ...

SpliSense is currently conducting a Phase IIb trial with its antisense oligonucleotide therapy.

After the deal closes, expected in the fourth quarter of this year, Altaris plans to combine Simulations Plus with its existing portfolio company, Chemical Computing Group, which ...

A bill before Congress would amend the COINS Act, which restricts American investment in sensitive technologies abroad, to ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...